
Olix and Lilly Sign Global Deal for Mash and Cardiometabolic
OliX to Receive Initial Payment and Complete Phase 1 Clinical Trial in Australia OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced a global
OliX to Receive Initial Payment and Complete Phase 1 Clinical Trial in Australia OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced a global
Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today
Fuel up with free Health Tech Insights